Suppr超能文献

2017 年哮喘研究进展:发病机制、生物制剂和遗传学。

Advances in asthma in 2017: Mechanisms, biologics, and genetics.

机构信息

Division of Allergy and Immunology, Department of Pediatrics, Nationwide Children's Hospital, Ohio State University College of Medicine, Columbus, Ohio.

Section of Allergy and Immunology, Division of Pulmonary Allergy Critical Care Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pa.

出版信息

J Allergy Clin Immunol. 2018 Nov;142(5):1423-1436. doi: 10.1016/j.jaci.2018.08.033. Epub 2018 Sep 11.

Abstract

This review summarizes some of the most significant advances in asthma research over the past year. We first focus on novel discoveries in the mechanism of asthma development and exacerbation. This is followed by a discussion of potential new biomarkers, including the use of radiographic markers of disease. Several new biologics have become available to the clinician in the past year, and we summarize these advances and how they can influence the clinical delivery of asthma care. After this, important findings in the genetics of asthma and heterogeneity in phenotypes of the disease are explored, as is the role the environment plays in shaping the development and exacerbation of asthma. Finally, we conclude with a discussion of advances in health literacy and how they will affect asthma care.

摘要

本综述总结了过去一年中哮喘研究的一些重要进展。我们首先关注哮喘发病和恶化机制方面的新发现。接着讨论了一些新的潜在生物标志物,包括疾病放射学标志物的应用。过去一年中,临床医生可获得几种新的生物制剂,我们对这些进展以及它们如何影响哮喘治疗的临床应用进行了总结。接下来,我们探讨了哮喘遗传学和疾病表型异质性方面的重要发现,以及环境在塑造哮喘发病和恶化方面所起的作用。最后,我们讨论了健康素养方面的进展及其对哮喘治疗的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验